about
Role of nuclear receptor corepressor RIP140 in metabolic syndromeIncretin based therapies: a novel treatment approach for non-alcoholic fatty liver diseaseDevelopment of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end productsRole of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver diseaseAnimal models of metabolic syndrome: a reviewThe Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver DiseaseDietary Tributyrin Supplementation Attenuates Insulin Resistance and Abnormal Lipid Metabolism in Suckling Piglets with Intrauterine Growth RetardationThe PNPLA3 rs738409 G-allele associates with reduced fasting serum triglyceride and serum cholesterol in Danes with impaired glucose regulationEffects of methyl mercury exposure on pancreatic beta cell development and function.Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels.2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-elicited effects on bile acid homeostasis: Alterations in biosynthesis, enterohepatic circulation, and microbial metabolism.Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.Expression of fatty acid synthase in nonalcoholic fatty liver disease.A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease.Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some peopleEffects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammationCausative role of gut microbiota in non-alcoholic fatty liver disease pathogenesisSystems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease.Rodent models for metabolic syndrome research.Protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial.Susceptibility and gene interaction study of the angiotensin II type 1 receptor (AGTR1) gene polymorphisms with non-alcoholic fatty liver disease in a multi-ethnic population.The association between nonalcoholic fatty pancreas disease and diabetesRisk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C > G) in the development of fatty liverLiver fat content, evaluated through semi-quantitative ultrasound measurement, is associated with impaired glucose profiles: a community-based study in ChineseA study of standardized extracts of Picrorhiza kurroa Royle ex Benth in experimental nonalcoholic fatty liver disease.Obesity, diabetes mellitus, and liver fibrosis.Cytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis.Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular riskHCC development is associated to peripheral insulin resistance in a mouse model of NASH.Non-alcoholic fatty liver disease and psoriasis: So far, so near.Identification of eQTLs for hepatic Xbp1s and Socs3 gene expression in mice fed a high-fat, high-caloric diet.AdipoQ T45 G and G276 T Polymorphisms and Susceptibility to Nonalcoholic Fatty Liver Disease Among Asian Populations: A Meta-Analysis and Meta-Regression.Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet.A model of metabolic syndrome and related diseases with intestinal endotoxemia in rats fed a high fat and high sucrose diet.Increased expression of zinc finger protein 267 in non-alcoholic fatty liver disease.Diagnostic accuracy of acyl-ghrelin and it association with non-alcoholic fatty liver disease in type 2 diabetic patientsA weighty problem: metabolic perturbations and the obesity-cancer link.Carotenoids and non-alcoholic fatty liver disease.Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease.Association of PNPLA3 rs738409 and TM6SF2 rs58542926 with health services utilization in a population-based study.
P2860
Q24610857-D73AB06D-FFA9-4D5B-93FE-BC06D1710BBCQ26827183-3E8FE59B-0E1E-4EDD-9A23-70D90C7122C1Q26861308-AFF631A8-35BC-4E09-AB17-EAA27422B4BBQ27005988-1392E567-D6F5-4496-9A03-BBEF42933C0BQ28072861-8A7F2BD2-557B-4BA3-9E49-2405729B8D64Q28078754-910A81BF-BA14-4248-947B-6955B91BFB57Q28547562-B8A29655-EF8C-4A69-9053-7C90C9457992Q28727506-B285CC13-DFAA-49DC-AA64-E41EF75E8906Q30245651-FEAF6126-8CF5-44BF-9BFA-AF1B2A6370F0Q33906456-79D511A5-DF8A-4077-8AE9-6FFF07D02ED1Q33918357-8EC25B29-ED99-413C-BF32-F3C93FE26BB8Q33948324-FD7DCA8E-C36C-446D-B92A-8AA81B1A0D2DQ33962008-0CD49AD8-7022-4ABB-9D11-AE0229EC8A47Q34301287-CF5C2230-FD2A-4E82-BF43-4AFDBAC88BD2Q34333036-06735A27-B278-4F81-8145-C340FDC69B3CQ34405101-213A8FCD-C1B1-4301-9502-582F4A581225Q34462482-12E39B1C-0D01-4EC9-8DEA-C7048F322B24Q34467142-09B353E5-69A4-48BB-ABA6-78216BD8DD95Q34479248-9605A43B-FB27-4C8A-A31D-CC821FF878C0Q34503852-8E4FF4BD-5553-49E3-A0EC-74CDEB93AC23Q34618881-21BA5CAC-981F-46E1-A786-00B89BE6CFD3Q34720662-FEE487DB-6136-4B28-A0E8-F160A0BE75CFQ34728811-0024A24E-3F4C-451A-B654-25FC188B567EQ34811955-3D5D47B6-0BDA-437B-BE51-7834E0BA4960Q34921969-31BAD757-454F-4CC7-A51A-57BE6F970EE6Q34979922-50AD1B16-73E7-4DE3-BDF9-0F106E0D148CQ35064093-8D002B61-89F2-4BA4-83B7-BF5E7523BD3BQ35171570-50F7093C-4D54-4641-9115-331D9312C8E5Q35172679-FDDC2147-F8C7-4D08-ABEF-482095529004Q35237307-37B021A8-18B2-422E-82C8-E41A6DF1EF08Q35330118-3502C15E-15DF-4EFB-9241-EA35D061050EQ35408626-075D7B0D-003C-4E6D-B615-2171B5C48C8AQ35474502-E009509A-0FD6-43D3-8D15-C042B546DB0CQ35515672-97672CB9-2AEA-41E7-B777-ECCB679D4655Q35532289-866EA152-4287-4E4E-BD77-B643C072C464Q35626631-B3DB71A1-06A6-44B8-B514-3EDD2BA694B1Q35689545-23986D94-61BF-4943-A828-87DF41126C3CQ35737427-A80C1AFD-E7BD-4D1E-BD94-D16A679C3F43Q35760391-E55064EA-3D2A-4D26-9E46-577643F70554Q35914994-742652C2-AFB9-4C0A-A755-50955026B769
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
From the metabolic syndrome to NAFLD or vice versa?
@en
From the metabolic syndrome to NAFLD or vice versa?
@nl
type
label
From the metabolic syndrome to NAFLD or vice versa?
@en
From the metabolic syndrome to NAFLD or vice versa?
@nl
prefLabel
From the metabolic syndrome to NAFLD or vice versa?
@en
From the metabolic syndrome to NAFLD or vice versa?
@nl
P2093
P1476
From the metabolic syndrome to NAFLD or vice versa?
@en
P2093
Anna Kotronen
Ester Vanni
Gianluca Svegliati-Baroni
Samuele De Minicis
P304
P356
10.1016/J.DLD.2010.01.016
P577
2010-03-06T00:00:00Z